Quipt Home Medical Corp. (QIPT)
NASDAQ: QIPT · Real-Time Price · USD
2.420
-0.030 (-1.22%)
Nov 20, 2024, 4:00 PM EST - Market closed
Quipt Home Medical Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 - 2014 |
Revenue | 244.23 | 211.68 | 127.64 | 94.39 | 72.64 | 80.97 | Upgrade
|
Revenue Growth (YoY) | 29.31% | 65.84% | 35.22% | 29.95% | -10.29% | 14.82% | Upgrade
|
Cost of Revenue | 67.54 | 57.9 | 33.21 | 28.17 | 19.93 | 22.58 | Upgrade
|
Gross Profit | 176.69 | 153.78 | 94.42 | 66.22 | 52.71 | 58.38 | Upgrade
|
Selling, General & Admin | 119.79 | 103.22 | 65.2 | 44.66 | 38.63 | 43.53 | Upgrade
|
Other Operating Expenses | - | - | -4.89 | - | -0.14 | 0.08 | Upgrade
|
Operating Expenses | 172.18 | 148.67 | 88.85 | 67.39 | 53.2 | 59.64 | Upgrade
|
Operating Income | 4.51 | 5.11 | 5.57 | -1.17 | -0.49 | -1.25 | Upgrade
|
Interest Expense | -7.64 | -6.61 | -2.08 | -1.99 | -1.84 | -2.54 | Upgrade
|
Interest & Investment Income | - | - | - | - | - | 0.03 | Upgrade
|
Earnings From Equity Investments | -0.33 | -0.09 | - | - | - | - | Upgrade
|
Currency Exchange Gain (Loss) | -0.47 | 0.11 | -0.14 | -0.17 | 0.45 | - | Upgrade
|
Other Non Operating Income (Expenses) | - | - | - | -2.11 | -0.41 | -0.63 | Upgrade
|
EBT Excluding Unusual Items | -3.93 | -1.48 | 3.35 | -5.45 | -2.29 | -4.39 | Upgrade
|
Merger & Restructuring Charges | -0.53 | -1.27 | -0.8 | -0.23 | -0.09 | -1.85 | Upgrade
|
Impairment of Goodwill | - | - | - | - | - | -0.53 | Upgrade
|
Gain (Loss) on Sale of Assets | 0.04 | 0.08 | -0.05 | 0.09 | 0.07 | 0.02 | Upgrade
|
Legal Settlements | - | - | - | -0.15 | - | - | Upgrade
|
Other Unusual Items | - | -0.03 | 0.43 | -3.59 | -1.27 | -2.12 | Upgrade
|
Pretax Income | -4.42 | -2.7 | 2.94 | -9.33 | -3.58 | -8.87 | Upgrade
|
Income Tax Expense | 0.56 | 0.09 | -1.9 | -3.16 | 0.13 | 0.27 | Upgrade
|
Earnings From Continuing Operations | -4.98 | -2.78 | 4.84 | -6.17 | -3.7 | -9.14 | Upgrade
|
Earnings From Discontinued Operations | - | - | - | - | -0.87 | 1.76 | Upgrade
|
Net Income | -4.98 | -2.78 | 4.84 | -6.17 | -4.57 | -7.39 | Upgrade
|
Net Income to Common | -4.98 | -2.78 | 4.84 | -6.17 | -4.57 | -7.39 | Upgrade
|
Shares Outstanding (Basic) | 42 | 39 | 34 | 30 | 23 | 21 | Upgrade
|
Shares Outstanding (Diluted) | 42 | 39 | 36 | 30 | 23 | 21 | Upgrade
|
Shares Change (YoY) | 15.35% | 6.35% | 19.27% | 33.96% | 9.68% | 9.38% | Upgrade
|
EPS (Basic) | -0.12 | -0.07 | 0.14 | -0.20 | -0.20 | -0.36 | Upgrade
|
EPS (Diluted) | -0.12 | -0.07 | 0.13 | -0.20 | -0.20 | -0.36 | Upgrade
|
Free Cash Flow | 33.12 | 33.68 | 17.18 | 12.72 | 13.94 | 10.9 | Upgrade
|
Free Cash Flow Per Share | 0.78 | 0.87 | 0.47 | 0.42 | 0.61 | 0.53 | Upgrade
|
Gross Margin | 72.34% | 72.65% | 73.98% | 70.15% | 72.56% | 72.11% | Upgrade
|
Operating Margin | 1.85% | 2.42% | 4.37% | -1.24% | -0.68% | -1.55% | Upgrade
|
Profit Margin | -2.04% | -1.32% | 3.79% | -6.54% | -6.29% | -9.12% | Upgrade
|
Free Cash Flow Margin | 13.56% | 15.91% | 13.46% | 13.47% | 19.19% | 13.46% | Upgrade
|
EBITDA | 47.71 | 39.61 | 24.4 | 13.84 | 11.88 | 12.18 | Upgrade
|
EBITDA Margin | 19.54% | 18.71% | 19.12% | 14.66% | 16.36% | 15.05% | Upgrade
|
D&A For EBITDA | 43.2 | 34.5 | 18.83 | 15.01 | 12.38 | 13.44 | Upgrade
|
EBIT | 4.51 | 5.11 | 5.57 | -1.17 | -0.49 | -1.25 | Upgrade
|
EBIT Margin | 1.85% | 2.42% | 4.37% | -1.24% | -0.68% | -1.54% | Upgrade
|
Revenue as Reported | 255.81 | 221.74 | 139.86 | 102.35 | 72.64 | 80.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.